Publication:
Anti-Inflammatory and Antioxidant Effects of Infliximab on Acute Lung Injury in a Rat Model of Intestinal Ischemia/Reperfusion

dc.authorscopusid24437302600
dc.authorscopusid7006356462
dc.authorscopusid59620576800
dc.authorscopusid16175986900
dc.authorscopusid36023238400
dc.contributor.authorGüzel, A.
dc.contributor.authorKanter, M.
dc.contributor.authorGüzel, A.
dc.contributor.authorPergel, A.
dc.contributor.authorErboǧa, M.
dc.date.accessioned2020-06-21T14:19:08Z
dc.date.available2020-06-21T14:19:08Z
dc.date.issued2012
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Güzel] Ahmet, Department of Pediatrics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Kanter] Mehmet, Department of Histology and Embryology, Trakya Üniversitesi, Edirne, Edirne, Turkey; [Güzel] Aygül, Department of Chest Disease, Samsun Chest Disease and Chest Surgery Hospital, Samsun, Samsun, Turkey; [Pergel] Ahmet, Department of Surgery, Recep Tayyip Erdogan University, Rize, Turkey; [Erboǧa] Mustafa, Department of Histology and Embryology, Trakya Üniversitesi, Edirne, Edirne, Turkeyen_US
dc.description.abstractThe purpose of this study was to investigate the role of infliximab on acute lung injury induced by intestinal ischemia/reperfusion (I/R). A total of 30 male Wistar albino rats were divided into three groups: Sham, I/R and I/R? infliximab; each group contain 10 animals. Sham group animals underwent laparotomy without I/R injury. After I/R groups animals underwent laparotomy, 1 h of superior mesenteric artery ligation were followed by 1 h of reperfusion. In the infliximab group, 3 days before I/R, infliximab (3 mg/kg) was administered by intravenously. All animals were sacrificed at the end of reperfusion and lung tissues samples were obtained for biochemical and histopathological investigation in all groups. To date, no more biochemical and histopathological changes on intestinal I/R injury in rats by infliximab treatment have been reported. Infliximab treatment significantly decreased the elevated tissue malondialdehyde levels and increased of reduced superoxide dismutase, and glutathione peroxidase enzyme activities in lung tissues samples. Intestinal I/R caused severe histopathological injury including edema, hemorrhage, increased thickness of the alveolar wall and a great number of inflammatory cells that infiltrated the interstitium and alveoli. Infliximab treatment significantly attenuated the severity of intestinal I/R injury. Furthermore, there is a significant reduction in the activity of inducible nitric oxide synthase and arise in the expression of surfactant protein D in lung tissue of acute lung injury induced by intestinal I/R with infliximab therapy. It was concluded that infliximab treatment might be beneficial in acute lung injury, therefore, shows potential for clinical use. Because of its anti-inflammatory and antioxidant effects, infliximab pretreatment may have protective effects in acute lung injury induced by intestinal I/R. © Springer Science+Business Media B.V. 2012.en_US
dc.identifier.doi10.1007/s10735-012-9396-0
dc.identifier.endpage369en_US
dc.identifier.issn1567-2379
dc.identifier.issn1567-2387
dc.identifier.issue3en_US
dc.identifier.pmid22389028
dc.identifier.scopus2-s2.0-84865630968
dc.identifier.scopusqualityQ3
dc.identifier.startpage361en_US
dc.identifier.urihttps://doi.org/10.1007/s10735-012-9396-0
dc.identifier.urihttps://hdl.handle.net/20.500.12712/16506
dc.identifier.volume43en_US
dc.identifier.wosWOS:000307288800013
dc.identifier.wosqualityQ4
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofJournal of Molecular Histologyen_US
dc.relation.journalJournal of Molecular Histologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcute Lung Injuryen_US
dc.subjectInfliximaben_US
dc.subjectiNOS and Surfactant Protein Den_US
dc.subjectIntestinal Ischemiaen_US
dc.subjectOxidative Stressen_US
dc.subjectRaten_US
dc.subjectReperfusionen_US
dc.titleAnti-Inflammatory and Antioxidant Effects of Infliximab on Acute Lung Injury in a Rat Model of Intestinal Ischemia/Reperfusionen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files